Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4945432017 | Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4945433010 | Product containing precisely levomefolate calcium 2.8 milligram and mecobalamin 2 milligram and pyridoxal phosphate 25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Is a | Levomefolic acid and mecobalamin and pyridoxal only product in oral dose form | true | Inferred relationship | Some | ||
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has precise active ingredient | Mecobalamin | true | Inferred relationship | Some | 1 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has basis of strength substance (attribute) | Mecobalamin | true | Inferred relationship | Some | 1 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has precise active ingredient | Pyridoxal phosphate (substance) | true | Inferred relationship | Some | 2 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has basis of strength substance (attribute) | Pyridoxal phosphate (substance) | true | Inferred relationship | Some | 2 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has precise active ingredient | Levomefolate calcium (substance) | true | Inferred relationship | Some | 3 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has basis of strength substance (attribute) | Levomefolate calcium (substance) | true | Inferred relationship | Some | 3 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Levomefolate calcium 2.8 mg and mecobalamin 2 mg and pyridoxal phosphate 25 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set